PE20071432A1 - Derivados de dihidrobenzofurano como agonistas o agonistas parciales de receptores metaloninergicos - Google Patents
Derivados de dihidrobenzofurano como agonistas o agonistas parciales de receptores metaloninergicosInfo
- Publication number
- PE20071432A1 PE20071432A1 PE2006000416A PE2006000416A PE20071432A1 PE 20071432 A1 PE20071432 A1 PE 20071432A1 PE 2006000416 A PE2006000416 A PE 2006000416A PE 2006000416 A PE2006000416 A PE 2006000416A PE 20071432 A1 PE20071432 A1 PE 20071432A1
- Authority
- PE
- Peru
- Prior art keywords
- agonists
- receptors
- derivatives
- metalloninergic
- dihidrobenzofuran
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
Abstract
SE REFIERE A DERIVADOS DE DIHIDROBENZOFURANO DE FORMULA (I) DONDE X ES O, S, SO(1-2), O -CH2-; R1 ES CN, HALOGENO, -R U -OR; R ES H O ALIFATICO(C1-C4) OPCIONALMENTE SUSTITUIDO CON F; Ar ES TIENILO, FURILO, PIRIDILO, O FENILO, OPCIONALMENTE SUSTITUIDOS; R2 ES H, ALQUILO(C1-C4); m ES 1 o 2; n ES 0 o 1; y ES 0 A 3. SON COMPUESTOS PREFERIDOS: (R)-N-[7-(2,6-DICLORO-FENIL)-5-FLUOR-2,3-DIHIDRO-BENZOFURAN-2-ILMETIL]-ACETAMIDA, N-[7-(2,6-DICLORO-FENIL)-2,3-DIHIDRO-BENZOFURAN-2-ILMETIL]-ACETAMIDA, CLORHIDRATO DE N-[7-(2-CLORO-FENIL)-2,3-DIHIDRO-BENZOFURAN-2-ILMETIL]-ACETAMIDA, ENTRE OTROS. ESTOS COMPUESTOS SON AGONISTAS O AGONISTAS PARCIALES DE RECEPTORES MELATONINERGICOS MT1 Y MT2 PUDIENDO SER UTILES EN EL TRATAMIENTO DEL DESORDEN DEL SUENO, DEPRESION, ANSIEDAD, STRESS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67406005P | 2005-04-22 | 2005-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20071432A1 true PE20071432A1 (es) | 2007-01-24 |
Family
ID=36955708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2006000416A PE20071432A1 (es) | 2005-04-22 | 2006-04-21 | Derivados de dihidrobenzofurano como agonistas o agonistas parciales de receptores metaloninergicos |
Country Status (13)
Country | Link |
---|---|
US (1) | US7470799B2 (es) |
EP (1) | EP1871754A1 (es) |
JP (1) | JP2008538571A (es) |
CN (1) | CN101180283A (es) |
AR (1) | AR055916A1 (es) |
AU (1) | AU2006239910A1 (es) |
BR (1) | BRPI0609988A2 (es) |
CA (1) | CA2605435A1 (es) |
GT (1) | GT200600167A (es) |
MX (1) | MX2007013065A (es) |
PE (1) | PE20071432A1 (es) |
TW (1) | TW200716584A (es) |
WO (1) | WO2006116136A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
BRPI0610028A2 (pt) * | 2005-04-22 | 2010-05-18 | Wyeth Corp | combinações terapêuticas para o tratamento ou a prevenção de distúrbios psicóticos |
BRPI0607536A2 (pt) * | 2005-04-22 | 2009-09-15 | Wyeth Corp | tratamento de dor |
BRPI0609988A2 (pt) | 2005-04-22 | 2010-05-18 | Wyeth Corp | derivados de diidrobenzofurano e usos dos mesmos |
EP1874756A1 (en) * | 2005-04-22 | 2008-01-09 | Wyeth | Chromane and chromene derivatives and uses thereof |
GT200600164A (es) * | 2005-04-22 | 2007-03-14 | Derivados de dihidrobenzofuranos y usos de los mismos | |
PE20061327A1 (es) * | 2005-04-22 | 2007-01-02 | Wyeth Corp | Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion |
MX2007013021A (es) * | 2005-04-22 | 2008-01-11 | Wyeth Corp | Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c. |
JP2008538577A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ジヒドロベンゾフラン誘導体およびその使用 |
BRPI0610046A2 (pt) * | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de benzodioxano e benzodioxolano e usos destes |
CA2606064A1 (en) * | 2005-04-24 | 2006-11-02 | Wyeth | Methods for modulating bladder function |
MX2008012212A (es) * | 2006-03-24 | 2008-10-02 | Wyeth Corp | Metodos para tratar trastornos cognitivos y otros afines. |
AR060493A1 (es) * | 2006-04-18 | 2008-06-18 | Wyeth Corp | Derivados de benzodioxano y benzodioxolano. procesos de obtencion. |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
WO2009046448A1 (en) | 2007-10-04 | 2009-04-09 | Intellikine, Inc. | Chemical entities and therapeutic uses thereof |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
US8637542B2 (en) | 2008-03-14 | 2014-01-28 | Intellikine, Inc. | Kinase inhibitors and methods of use |
US8993580B2 (en) | 2008-03-14 | 2015-03-31 | Intellikine Llc | Benzothiazole kinase inhibitors and methods of use |
WO2010006086A2 (en) | 2008-07-08 | 2010-01-14 | Intellikine, Inc. | Kinase inhibitors and methods of use |
US8476431B2 (en) | 2008-11-03 | 2013-07-02 | Itellikine LLC | Benzoxazole kinase inhibitors and methods of use |
JP5819831B2 (ja) | 2009-08-17 | 2015-11-24 | インテリカイン, エルエルシー | 複素環式化合物およびそれらの使用 |
TWI592411B (zh) | 2011-02-23 | 2017-07-21 | 英特爾立秦有限責任公司 | 激酶抑制劑之組合及其用途 |
US9938258B2 (en) | 2012-11-29 | 2018-04-10 | Karyopharm Therapeutics Inc. | Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof |
CN105209042B (zh) | 2013-03-22 | 2019-03-08 | 米伦纽姆医药公司 | 催化性mtorc 1/2抑制剂与选择性极光a激酶抑制剂的组合 |
KR102581373B1 (ko) | 2013-07-03 | 2023-09-20 | 카리오팜 쎄라퓨틱스, 인코포레이티드 | 치환된 벤조퓨라닐 및 벤즈옥사졸릴 화합물 및 이의 용도 |
US9994558B2 (en) | 2013-09-20 | 2018-06-12 | Karyopharm Therapeutics Inc. | Multicyclic compounds and methods of using same |
CN108137563A (zh) | 2015-08-18 | 2018-06-08 | 卡尔约药物治疗公司 | 用于治疗癌症的(S,E)-3-(6-氨基吡啶-3-基)-N-((5-(4-(3-氟-3-甲基吡咯烷-l-羰基)苯基)-7-(4-氟苯基)苯并呋喃-2-基)甲基)丙烯酰胺 |
US10858347B2 (en) | 2015-12-31 | 2020-12-08 | Karyopharm Therapeutics Inc. | Multicyclic compounds and uses thereof |
US20210052600A1 (en) | 2017-12-27 | 2021-02-25 | Takeda Pharmaceutical Company Limited | Therapeutic agents for stress urinary incontinence and incotinence of feces |
GB201801128D0 (en) * | 2018-01-24 | 2018-03-07 | Univ Oxford Innovation Ltd | Compounds |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2680366B1 (fr) * | 1991-08-13 | 1995-01-20 | Adir | Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
US5541228A (en) * | 1994-10-14 | 1996-07-30 | Bristol-Myers Squibb Co. | Melatonergic agents |
US5530012A (en) * | 1994-12-22 | 1996-06-25 | Bristol-Myers Squibb Co. | 3-alkoxybenzylpiperidine derivatives as melatonergic agents |
FR2737725B1 (fr) * | 1995-08-08 | 1997-10-31 | Valentonine | Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament |
WO1999062515A1 (en) * | 1998-06-05 | 1999-12-09 | Bristol-Myers Squibb Company | Heterocyclic cis cyclopropane derivatives as melatonergic agents |
PT1189900E (pt) * | 1999-06-30 | 2004-05-31 | Bristol Myers Squibb Co | Derivados de aminopirrolidina heterociclicos utilizados como agentes melatonergicos |
US6569894B1 (en) * | 2001-10-04 | 2003-05-27 | Bristol-Myers Squibb Company | Arylalkylbenzofuran derivatives as melatonergic agents |
US6737431B2 (en) * | 2002-03-12 | 2004-05-18 | Bristol-Myers Squibb Company | Benzoxazole derivatives as novel melatonergic agents |
US7728155B2 (en) * | 2003-10-24 | 2010-06-01 | Wyeth Llc | Dihydrobenzofuranyl alkanamines and methods for using same as cns agents |
US7435837B2 (en) * | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US20050261347A1 (en) * | 2003-10-24 | 2005-11-24 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
US20050251347A1 (en) * | 2004-05-05 | 2005-11-10 | Pietro Perona | Automatic visual recognition of biological particles |
WO2006000902A1 (en) | 2004-06-25 | 2006-01-05 | Pfizer Products Inc. | Dihydrobenzofuran compounds and uses thereof |
GT200500296A (es) * | 2004-10-21 | 2006-10-02 | Sintesis asimetrica de derivados del dehidrobenzofurano | |
GT200500297A (es) * | 2004-10-21 | 2006-10-27 | Sintesis asimetrica de dehidrobenzofuranos sustituidos | |
PE20061319A1 (es) * | 2005-04-22 | 2006-12-28 | Wyeth Corp | Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina |
BRPI0610028A2 (pt) * | 2005-04-22 | 2010-05-18 | Wyeth Corp | combinações terapêuticas para o tratamento ou a prevenção de distúrbios psicóticos |
PE20061327A1 (es) * | 2005-04-22 | 2007-01-02 | Wyeth Corp | Combinaciones de derivados de benzofurano y un antidepresivo para el tratamiento o la prevencion de la depresion |
GT200600164A (es) * | 2005-04-22 | 2007-03-14 | Derivados de dihidrobenzofuranos y usos de los mismos | |
BRPI0607536A2 (pt) * | 2005-04-22 | 2009-09-15 | Wyeth Corp | tratamento de dor |
AU2006239917A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse |
JP2008538577A (ja) * | 2005-04-22 | 2008-10-30 | ワイス | ジヒドロベンゾフラン誘導体およびその使用 |
EP1874756A1 (en) * | 2005-04-22 | 2008-01-09 | Wyeth | Chromane and chromene derivatives and uses thereof |
BRPI0610046A2 (pt) * | 2005-04-22 | 2010-05-25 | Wyeth Corp | derivados de benzodioxano e benzodioxolano e usos destes |
BRPI0609988A2 (pt) | 2005-04-22 | 2010-05-18 | Wyeth Corp | derivados de diidrobenzofurano e usos dos mesmos |
MX2007013021A (es) * | 2005-04-22 | 2008-01-11 | Wyeth Corp | Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c. |
CA2606064A1 (en) * | 2005-04-24 | 2006-11-02 | Wyeth | Methods for modulating bladder function |
-
2006
- 2006-04-21 BR BRPI0609988-2A patent/BRPI0609988A2/pt not_active Application Discontinuation
- 2006-04-21 EP EP06751037A patent/EP1871754A1/en not_active Withdrawn
- 2006-04-21 WO PCT/US2006/015172 patent/WO2006116136A1/en active Application Filing
- 2006-04-21 TW TW095114311A patent/TW200716584A/zh unknown
- 2006-04-21 JP JP2008507935A patent/JP2008538571A/ja active Pending
- 2006-04-21 AU AU2006239910A patent/AU2006239910A1/en not_active Abandoned
- 2006-04-21 CN CNA2006800176375A patent/CN101180283A/zh active Pending
- 2006-04-21 GT GT200600167A patent/GT200600167A/es unknown
- 2006-04-21 PE PE2006000416A patent/PE20071432A1/es not_active Application Discontinuation
- 2006-04-21 US US11/408,653 patent/US7470799B2/en not_active Expired - Fee Related
- 2006-04-21 AR ARP060101591A patent/AR055916A1/es not_active Application Discontinuation
- 2006-04-21 CA CA002605435A patent/CA2605435A1/en not_active Abandoned
- 2006-04-21 MX MX2007013065A patent/MX2007013065A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2007013065A (es) | 2008-01-14 |
AR055916A1 (es) | 2007-09-12 |
WO2006116136A1 (en) | 2006-11-02 |
JP2008538571A (ja) | 2008-10-30 |
TW200716584A (en) | 2007-05-01 |
CN101180283A (zh) | 2008-05-14 |
US7470799B2 (en) | 2008-12-30 |
AU2006239910A1 (en) | 2006-11-02 |
EP1871754A1 (en) | 2008-01-02 |
BRPI0609988A2 (pt) | 2010-05-18 |
GT200600167A (es) | 2007-03-14 |
US20060246551A1 (en) | 2006-11-02 |
CA2605435A1 (en) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20071432A1 (es) | Derivados de dihidrobenzofurano como agonistas o agonistas parciales de receptores metaloninergicos | |
PE20020858A1 (es) | Indanil aminas aciladas | |
PE20061088A1 (es) | Compuestos de bis arilo y heteroarilo sustituidos como antagonistas selectivos de 5ht2a | |
PE20050896A1 (es) | Intermediarios de quinolina como inhibidores de tirosina quinasas de receptores y la sintesis de los mismos | |
PE20071251A1 (es) | Derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
CR9459A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
PE20061318A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos | |
PE20040935A1 (es) | Analogos de 2-quinazolina sustituida-4-ilamina como moduladores de los receptores de capsaicina | |
PE20020470A1 (es) | Derivados de pirazol como inhibidores de las enzimas proteina quinasas | |
PE20040801A1 (es) | Derivados de pirazina y piridina 5-sustituidos como activadores de glucoquinasa | |
PE20060401A1 (es) | Derivados de n-(2-bencil)-2-fenil-butanamidas y propanamidas como moduladores del receptor de androgeno | |
PE20091843A1 (es) | Inhibidores de catepsina c | |
PE20060689A1 (es) | Derivados de sulfonamidas como antagonistas de receptores orexina 2 | |
PE20060737A1 (es) | 3-AMINO-PIRAZOL[3,4b] PIRIDINAS COMO INHIBIDORES DE PROTEINTIROSINQUINASAS Y SU PREPARACION | |
PE20060585A1 (es) | Derivados de 2-amido-4-feniltiazol como antagonistas de quimiocinas y su preparacion | |
PE20211700A1 (es) | Compuesto heterociclico y su uso | |
PE20060273A1 (es) | Derivados de tetrahidroisoquinolilsulfonamidas como moduladores del receptor h3 | |
PE20110703A1 (es) | Acidos naftilaceticos | |
AR050576A1 (es) | Oxadiazolonas con actividad agonista de ppar-delta. composiciones farmaceuticas. | |
PE20121049A1 (es) | Derivados de pirazinooxazepina | |
PE20061446A1 (es) | Compuestos de bencimidazol-carboxamida como agonistas de receptores 5-ht4 | |
PE20071089A1 (es) | Compuesto heterociclico fusionado como inhibidor de tirosina quinasa | |
PE20220425A1 (es) | Derivado de 1,1-dioxido de 3-amino-4h-benzo[e][1,2,4]tiadiazina como inhibidores de mrgx2 | |
PE20091649A1 (es) | Derivados de pirrolidinilo | |
PE20050312A1 (es) | Compuestos de peptidilo como inhibidores de catepsina s |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |